Thomas W Stoelk
CIK 1333331 · View on SEC EDGAR ↗
First SEC filing: April 11, 2017 · Latest: April 11, 2017
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| April 8, 2017 | NOG | F | 44,229 | $2.45 | $108,361 | 1,106,446 Direct | -3.84% | Disposed | 10.3% (price as of 2026-08-21) |
| March 15, 2017 | NOG | F | 42,313 | $2.60 | $110,014 | 1,150,675 Direct | -3.55% | Disposed | 4.0% (price as of 2026-08-21) |
| March 13, 2017 | NOG | F | 7,050 | $2.70 | $19,035 | 1,192,988 Direct | -0.59% | Disposed | 0.1% (price as of 2026-08-21) |
| March 10, 2017 | NOG | D | 85,383 | — | — | 1,037,111 Direct | -7.61% | Disposed | (price as of 2026-08-21) |
| March 10, 2017 | NOG | A | 162,927 | — | — | 1,200,038 Direct | +15.71% | Acquired | (price as of 2026-08-21) |
| March 1, 2017 | NOG | F | 20,909 | $3.20 | $66,909 | 1,122,494 Direct | -1.83% | Disposed | -15.5% (price as of 2026-08-21) |
| June 1, 2016 | NOG | F | 15,540 | $4.55 | $70,707 | 1,143,403 Direct | -1.34% | Disposed | -40.6% (price as of 2026-08-21) |
| April 8, 2016 | NOG | A | 341,530 | — | — | 1,158,943 Direct | +41.78% | Acquired | (price as of 2026-08-21) |
| April 8, 2016 | NOG | A | 341,530 | — | — | 817,413 Direct | +71.77% | Acquired | (price as of 2026-08-21) |
| April 1, 2016 | NOG | F | 5,779 | $3.82 | $22,076 | 475,883 Direct | -1.20% | Disposed | -29.2% (price as of 2026-08-21) |
| March 13, 2016 | NOG | F | 7,050 | $3.91 | $27,566 | 481,662 Direct | -1.44% | Disposed | -30.9% (price as of 2026-08-21) |
| March 10, 2016 | NOG | A | 245,049 | — | — | 488,712 Direct | +100.57% | Acquired | (price as of 2026-08-21) |
| March 1, 2016 | NOG | F | 20,712 | $3.33 | $68,971 | 243,663 Direct | -7.83% | Disposed | -18.8% (price as of 2026-08-21) |
| June 1, 2015 | NOG | F | 10,300 | $6.80 | $70,040 | 264,375 Direct | -3.75% | Disposed | -60.2% (price as of 2026-08-21) |
| April 1, 2015 | NOG | F | 4,150 | $8.01 | $33,242 | 274,675 Direct | -1.49% | Disposed | -66.2% (price as of 2026-08-21) |
| March 13, 2015 | NOG | F | 5,064 | $7.09 | $35,904 | 278,825 Direct | -1.78% | Disposed | -61.9% (price as of 2026-08-21) |
| Feb. 27, 2015 | NOG | A | 121,093 | — | — | 283,889 Direct | +74.38% | Acquired | (price as of 2026-08-21) |
| June 1, 2014 | NOG | F | 11,800 | $15.08 | $177,944 | 162,796 Direct | -6.76% | Disposed | -82.1% (price as of 2026-08-21) |
| April 1, 2014 | NOG | F | 5,266 | $14.46 | $76,146 | 174,596 Direct | -2.93% | Disposed | -81.3% (price as of 2026-08-21) |
| March 13, 2014 | NOG | A | 40,831 | — | — | 179,862 Direct | +29.37% | Acquired | (price as of 2026-08-21) |
| Dec. 12, 2013 | NOG | F | 4,477 | $14.78 | $66,170 | 138,989 Direct | -3.12% | Disposed | -81.7% (price as of 2026-08-21) |
| March 29, 2013 | NOG | A | 33,466 | — | — | 143,466 Direct | +30.42% | Acquired | (price as of 2026-08-21) |
| June 1, 2012 | NOG | A | 100,000 | — | — | 110,000 Direct | +1000.00% | Acquired | (price as of 2026-08-21) |
| Dec. 12, 2011 | NOG | A | 10,000 | — | — | 10,000 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2018 | $42,917 | — | — | — | — | — | $29,183 | $72,100 |
| 2017 | $515,000 | — | $403,853 | — | — | — | $63,581 | $982,434 |
| 2016 | $508,333 | $250,000 | $2,671,349 | — | $508,333 | — | $62,099 | $4,000,114 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.